Delphine Bourneau-Martin, Aurelie Grandvuillemin, Marina Babin, Charlotte Mullet, Hillary Said, Morgane Cellier, Helene Geniaux, Sophie Gautier, Mathilde Beurrier, Gwenaelle Veyrac, Laurence Lagarce, Marie-Laure Laroche, Marie Briet
OBJECTIVES: Drug shortages are of increasing concern to worldwide public health. The consequences of drug shortages for patient safety have been little studied, especially from a pharmacovigilance point of view. In this context, the network of French pharmacovigilance centres conducted the CIRUPT study (Conséquences Iatrogènes des RUPTures de stock/iatrogenic consequences of drug shortages) based on a prospective campaign of adverse effects occurring in the context of drug shortage notifications...
April 15, 2024: European Journal of Hospital Pharmacy. Science and Practice